Through
4/26
Antibodies to coronavirus in pregnant women cross the placenta efficiently, and are found at similar concentrations in their newborns, according to a large study from researchers at the Perelman School of Medicine.
Patients with inactive cancer and not currently undergoing treatments also face a significantly higher risk of severe illness from COVID-19, with Black cancer patients twice as likely to test positive for the virus.
A Penn Medicine study finds that mortality rates of critically ill patients have progressively declined from the first surge of the pandemic, suggesting that hospital staff rapidly improved their management even before widespread use of evidence-based treatments.
The lab of César de la Fuente is working on a paper-based biosensor that could provide results in minutes. Clinical trials began Jan. 5.
Discovering wide variation in hospitals’ COVID-19 survival rates, researchers found that the levels of COVID-19 in the surrounding community was likely the driving factor.
As the COVID-19 vaccine is being distributed across the country, new research out of the Department of Philosophy shows that knowledge about the nature of science can combat political biases.
National efforts to develop a COVID-19 vaccine at ‘warp speed’ are beginning to yield a safe and effective vaccine. But this important milestone is only the first step in an equally important challenge: getting a majority of the U.S. public vaccinated.
In a Q&A, Penn Medicine’s James M. Wilson discusses using adeno-associated viral vectors to transport a lab-made antibody cocktail into the body. This method, delivered via nasal spray or mist, has the potential to act as a “bioshield” against SARS-CoV-2.
By week’s end, the health system expects to receive about 9,275 doses of the Pfizer vaccine for its frontline teams.
Survivors of COVID-19 often have health ramifications from their illness and hospital stay, and until now, no data has been available on the outcomes of COVID-19 patients discharged home after hospitalization and their recovery needs.
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for receiving awards from the Franklin Institute and subsequently being honored with a Nobel Prize.
FULL STORY →
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues finds that long COVID’s neurological symptoms, like brain fog, memory loss, and fatigue, may stem from serotonin reduction.
FULL STORY →
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that serotonin could be a target for long COVID treatment.
FULL STORY →